Stay updated on Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.

Latest updates to the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page
- Check6 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. No changes to the study details or substantive content.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all be about the study, and updated the revision to v3.3.1. The previous wording stating publications come from PubMed (and the older revision v3.2.0) was removed.SummaryDifference0.1%

- Check20 days agoChange DetectedThe notice about a lapse in government funding and possible update delays has been removed; the study page content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedComparison shows no substantive changes to the study details (eligibility, endpoints, or locations). The observed differences are minor visual/layout tweaks and do not affect the information presented.SummaryDifference0.4%

- Check63 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%

- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab Nivolumab Combo in Mesothelioma Clinical Trial page.